Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.

[1]  W. März,et al.  Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. , 2011, Atherosclerosis.

[2]  W. März,et al.  Vitamin D deficiency and myocardial diseases. , 2010, Molecular nutrition & food research.

[3]  E. Giovannucci,et al.  Benefit–risk assessment of vitamin D supplementation , 2010, Osteoporosis International.

[4]  E. Rozet,et al.  Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs , 2010, Osteoporosis International.

[5]  J. Simpson,et al.  Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. , 2010, JAMA.

[6]  Y. Shoenfeld,et al.  Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? , 2010, Annals of the rheumatic diseases.

[7]  H. Møller,et al.  High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[8]  John G Lewis,et al.  An anomalous result from gel tubes for vitamin D. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[9]  H. Bischoff-Ferrari.  Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary? , 2009, Best practice & research. Clinical rheumatology.

[10]  J. Souberbielle,et al.  Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  K. Myhr.  Vitamin D treatment in multiple sclerosis , 2009, Journal of the Neurological Sciences.

[12]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[13]  J B Wong,et al.  Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[14]  A. Struthers,et al.  Effect of vitamin D on blood pressure: a systematic review and meta-analysis , 2009, Journal of hypertension.

[15]  P. Goodwin,et al.  Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Alison M. MacLeod.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) , 2009 .

[17]  Z. Massy,et al.  Vitamin D affects survival independently of vascular calcification in chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[18]  R. Koerfer,et al.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. , 2009, The American journal of clinical nutrition.

[19]  C. Pierrot-Deseilligny.  Clinical implications of a possible role of vitamin D in multiple sclerosis , 2009, Journal of Neurology.

[20]  E John Orav,et al.  Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. , 2009, Archives of internal medicine.

[21]  Y. Shoenfeld,et al.  The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease , 2009, Nature Clinical Practice Rheumatology.

[22]  S. Tretli,et al.  Association between serum 25(OH)D and death from prostate cancer , 2009, British Journal of Cancer.

[23]  J. Nagpal,et al.  A double‐blind, randomized, placebo‐controlled trial of the short‐term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle‐aged, centrally obese men , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[24]  J. Fleet.  Molecular actions of vitamin D contributing to cancer prevention. , 2008, Molecular aspects of medicine.

[25]  R. Hiatt,et al.  Calcium plus vitamin D supplementation and the risk of breast cancer. , 2008, Journal of the National Cancer Institute.

[26]  J. Manson,et al.  Effect of Calcium and Vitamin D Supplementation on Blood Pressure: The Women's Health Initiative Randomized Trial , 2008, Hypertension.

[27]  N. Binkley,et al.  Evaluation and correction of low vitamin D status , 2008, Current osteoporosis reports.

[28]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[29]  W. März,et al.  Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography , 2008, Stroke.

[30]  S. Ish-shalom,et al.  Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. , 2008, The Journal of clinical endocrinology and metabolism.

[31]  R. Heaney.  Vitamin D in health and disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[32]  A. Scillitani,et al.  Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. , 2008, The Journal of clinical endocrinology and metabolism.

[33]  Z. Massy,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2008, Kidney international.

[34]  B. Boehm,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[35]  E. Rimm,et al.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. , 2008, Archives of internal medicine.

[36]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[37]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[38]  D. Tishkoff,et al.  Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. , 2008, Endocrinology.

[39]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[40]  M. Cutolo,et al.  Vitamin D in rheumatoid arthritis. , 2007, Autoimmunity reviews.

[41]  J. Chang-Claude,et al.  Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. , 2007, Carcinogenesis.

[42]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[43]  R. Vieth,et al.  Safety of vitamin D3 in adults with multiple sclerosis. , 2007, The American journal of clinical nutrition.

[44]  Y. Shoenfeld,et al.  Vitamin D and autoimmunity: new aetiological and therapeutic considerations , 2007, Annals of the rheumatic diseases.

[45]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[46]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[47]  E. Giovannucci,et al.  Vitamin D and prevention of breast cancer: Pooled analysis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[48]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.

[49]  R. Koerfer,et al.  Vitamin D and vascular calcification , 2007, Current opinion in lipidology.

[50]  G. Carmeliet,et al.  Vitamin D and cancer , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[51]  G. Tenderich,et al.  Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. , 2006, The American journal of clinical nutrition.

[52]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[53]  M. Holick.  Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. , 2004, The American journal of clinical nutrition.

[54]  B. Hollis,et al.  Vitamin D2 is much less effective than vitamin D3 in humans. , 2004, The Journal of clinical endocrinology and metabolism.

[55]  R. Heaney,et al.  Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption. , 2002, The Journal of clinical endocrinology and metabolism.

[56]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[57]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[58]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[59]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[60]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[61]  J. Haddad,et al.  COMPETITIVE PROTEIN-BINDING RADIOASSAY FOR 25-HYDROXYCHOLECALCIFEROL1 , 1971 .

[62]  C. Zoccali,et al.  Vitamin D levels and patient outcome in chronic kidney disease. , 2009, Kidney international.

[63]  A. Shao,et al.  Risk assessment for vitamin D. , 2007, The American journal of clinical nutrition.

[64]  J. Barkin.  Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer , 2007 .

[65]  J. Cerhan,et al.  Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. , 2004, Arthritis and rheumatism.

[66]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[67]  J. Haddad,et al.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol. , 1971, The Journal of clinical endocrinology and metabolism.